Today’s AI Top Pick: WING

8/5/2026 · Highly Shorted Oversold screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted OversoldWINGBUY NOW8.6 / 108/5/2026

Wingstop is the cleanest intersection of a real fundamental business, oversold tape, and multi-timeframe forecast agreement in this list. Fundamentals are the standout of the whole cohort: 28.77% operating margin, 82.62% gross margin, 16.15% profit margin, sales +7.6% YoY, analyst recom 1.48 (strong buy), and 72% target upside — this is not a busted penny name pretending to be a bounce candidate, it's a franchise compounder that has been dragged −65.15% over the last year and −49.05% YTD into RSI 29.98 with 17% short float. That's a classic 'washed-out quality' setup. The tape confirms across every horizon. On the 1d, WING is pinned at pos_in_21bar_range 0% with dd −22.82% and forecasts of +21.7% short / +86.5% mid / +83.9% long. The 4h shows fc_mid +19.1% and fc_long +57.3%. The 1wk shows −37.55% drawdown with fc_mid +36.2% and fc_long +66.1%. Even the 1h, while fc_short is a modest −0.76%, flips to +12.9% mid and +15.2% long — no timeframe is calling for further material downside. Near_term_bullish=1.0, bullish_prob=1.0. Position in range is 0–9.8% on every timeframe, so you are buying the low, not chasing. News flow is supportive rather than a landmine. The Aug-4 Q2 deep dive flags urban market softness and value promotions but no dilution, no legal action, no guidance withdrawal; the same day WING launched a new BBQ menu promotion (Carolina Gold / Jamaican Jerk) — a genuine catalyst for August comps. Contrast with KPTI (trial failure), CAPR (DMD regulatory setback + Piper downgrade), NRXP (all forecasts negative), MBRX (Benzinga flagged 'stock sinking'), BURU (dilutive offering) — those are all news-broken setups. Why today, not later: WING has already taken the drawdown (−37.55% off the weekly high), RSI is sub-30, and the daily forecast (+21.7% short) is the strongest 'go now' signal in the pack among names with actual fundamentals. Waiting for a lower low risks missing the earnings-adjacent snapback that the multi-TF forecasts are pricing in. BIRK has better fundamentals in some ways (7.5 vs 6.0 score) but its near-term forecasts are flat-to-negative (fc_short −0.6%/−1.7%/−1.59%) and near_term_bullish is only 0.2 — a 'wait' setup, not a 'buy now.'

Entry zone

$120.50–$123.50 (current $122.30, scale in on any dip toward the 21-bar low)

Stop loss

$109.50 (below the 4h dd_from_21bar_high of −13.89% and gives room under the round $110)

First target

$140–$145 (roughly the 4h fc_long +15% and 1d fc_short +21.7%)

Longer target

$175–$185 (aligns with 1wk fc_mid +36% / fc_long +66% and analyst target upside 72%)

Risks

Short float 17% + earnings-adjacent tape means a bad print could gap it 10–15% lower before the stop triggers
PE 28.85 / fwdPe 22.66 is not cheap — if same-store sales guidance disappoints again, multiple compression continues
The Aug-4 Q2 deep dive already flagged 'urban market challenges' — comp deceleration is the core bear thesis
1h fc_short is slightly negative (−0.76%), so intraday chop / another leg down to ~$118 is plausible before the bounce
Institutional ownership 133.85% signals crowded positioning — forced deleveraging could exaggerate any downside

Honorable mentions

PHATBest pure-tape setup: near_term_bullish 1.0, all TFs bullish, fc_short/mid/long +17.5%/+40.3%/+33.5% on daily, position 0–1.1% of range, fwdPe 9.15, salesYoY +110%, recom 1.3, targetUpside 159%. Slightly lower fundamental_score (4.0) and biotech binary risk keep it at #2 vs WING.

BIRKHighest fundamental_score (7.5) in the pool — PE 17, PEG 0.84, ROE 12.94, opMargin 24.5%, JP Morgan just raised PT to $58. But near_term_bullish only 0.2 and 1h/4h/1d fc_short all negative — this is BUY_PULLBACK, not BUY_NOW.

Full ranking (29)

#	Symbol	Verdict	Score	Read
1	WING	BUY NOW	8.6	Quality franchise at RSI 30, multi-TF forecasts +19% to +86%, positive product catalyst, position at range lows.
2	PHAT	BUY NOW	8.1	Cleanest tape alignment with near_term_bullish 1.0, fwdPe 9.15, sales +110% YoY, analyst target +159%.
3	BIRK	BUY PULLBACK	7.2	Best fundamentals (score 7.5, PEG 0.84, JPM PT $58) but near-term forecasts flat/negative — wait for a dip.
4	MNRO	BUY NOW	6.8	All TFs bullish (4h +41.9%, 1wk +65.5% long), near_term 0.8, position 9–16% of range, strategic review in play.
5	ADTN	BUY NOW	6.5	PEG 0.24, recom 1.44, targetUpside 79.5%, 4h fc_short +47.6%; but 1wk forecast negative caps upside.
6	FIP	BUY NOW	6.3	All TFs strongly bullish (4h/1d fc_long +55–58%), near_term 1.0, recom 1.0, targetUpside 192%; high debt/equity 3.96 is the caveat.
7	VERA	BUY PULLBACK	5.9	FDA approval catalyst for TRUTAKNA, targetUpside 173%, but 1wk forecasts turn negative — mixed signal.
8	COLM	BUY PULLBACK	5.5	Solid Q2 tariff-recovery beat, PE 14.9, but modest forecasts (fc_long only +5% on 1d) — limited edge.
9	SPRY	BUY NOW	5.4	Near_term 1.0, all TFs bullish, 1d fc_long +98%; new CEO transition is the wild card.
10	AESI	WAIT	5.0	Fresh Q2 results but negative fundamental_score (−3), 1wk fc_short −7.3%, mixed timeframe signals.
11	SG	WAIT	4.9	Earnings Aug 6 is binary; near_term 0.2, 4h fc_mid actually negative — sit out the print.
12	BIRD	AVOID	4.7	4h/1d forecasts +80–156% but 1wk collapses to −42%; micro-cap $20M with roe −153% is a lottery ticket.
13	JBGS	WAIT	4.6	Near_term 1.0 and RSI 23, but recom 5 (strong sell), targetUpside only 16.9% — analysts don't believe.
14	HTZ	WAIT	4.4	Massive forecasts (+270% on 1d mid) but roe −567%, earnings this week, 52-week low headline risk.
15	MBRX	AVOID	4.2	MIRACLE trial 37% CR is real, but $2M market cap and −87% YTD makes this a speculative gamble, not an investment.
16	TDOC	AVOID	4.0	All TF forecasts near-zero or negative, Q2 guidance under pressure, Citi lowered PT — thesis broken.
17	BTCT	AVOID	3.8	Micro-cap with private placement (dilution), fundamentals mostly null, purely speculative.
18	LESL	AVOID	3.5	−81% year, 4h fc_long actually negative, no clear catalyst — falling knife.
19	GLUE	AVOID	3.2	1d/1wk forecasts negative (−17% to −42%), roe −32%, ps 31.6 — overvalued and rolling over.
20	SNBR	AVOID	3.0	−98.5% YTD, $2.9M market cap; forecasts of +5000% are noise, not signal.
21	TC	AVOID	2.9	ROE −1080%, profit margin −406%, tiny ADR — the +500% forecasts are meaningless on this quality.
22	KPTI	AVOID	2.5	XPORT-EC-042 trial FAILED July 31, HC Wainwright downgraded — thesis is broken by news.
23	CAPR	AVOID	2.3	DMD therapy regulatory setback, Piper downgrade to Neutral, worst week ever — landmine hit.
24	NRXP	AVOID	2.2	All timeframe forecasts NEGATIVE (−16% to −66%), bullish_prob 0 — screen match is misleading.
25	YYGH	AVOID	2.0	−99.6% YTD, roe −260%, forecasts of +21000% are numerical garbage.
26	BURU	AVOID	1.8	Dilutive public offering just executed, opMargin −5942%, debt/equity 17.15.
27	PMI	AVOID	1.5	Reverse stock split for listing compliance + all forecasts −60% to −69% — capitulation, not opportunity.
28	GDC	AVOID	1.3	1wk fc_short/mid/long all −100%; forecast literally says goes to zero.
29	ADTX	AVOID	0.5	Down 100% YTD, price ~$0, forecasts of +7M% are mathematical artifacts — not tradeable.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord